These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 32748897)

  • 21. Upregulation of IL-11, an IL-6 Family Cytokine, Promotes Tumor Progression and Correlates with Poor Prognosis in Non-Small Cell Lung Cancer.
    Zhao M; Liu Y; Liu R; Qi J; Hou Y; Chang J; Ren L
    Cell Physiol Biochem; 2018; 45(6):2213-2224. PubMed ID: 29550807
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MED28 and forkhead box M1 (FOXM1) mediate matrix metalloproteinase 2 (MMP2)-dependent cellular migration in human nonsmall cell lung cancer (NSCLC) cells.
    Hsieh NT; Huang CY; Li CC; Wang IC; Lee MF
    J Cell Physiol; 2019 Jul; 234(7):11265-11275. PubMed ID: 30499104
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HOXB9 enhances the ability of lung cancer cells to penetrate the blood-brain barrier.
    Zheng H; Li C; Li Z; Zhu K; Bao H; Xiong J; Liang P
    Aging (Albany NY); 2020 Dec; 13(4):4999-5019. PubMed ID: 33411683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MiR-661 promotes tumor invasion and metastasis by directly inhibiting RB1 in non small cell lung cancer.
    Liu F; Cai Y; Rong X; Chen J; Zheng D; Chen L; Zhang J; Luo R; Zhao P; Ruan J
    Mol Cancer; 2017 Jul; 16(1):122. PubMed ID: 28716024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LATS2 as a poor prognostic marker regulates non-small cell lung cancer invasion by modulating MMPs expression.
    Wu A; Li J; Wu K; Mo Y; Luo Y; Ye H; Mai Z; Guo K; Wang Y; Li S; Chen H; Luo W; Yang Z
    Biomed Pharmacother; 2016 Aug; 82():290-7. PubMed ID: 27470365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phosphatidylethanolamine-binding protein 4 promotes the epithelial-to-mesenchymal transition in non-small cell lung cancer cells by activating the sonic hedgehog signaling pathway.
    Jian W; Bai Y; Li X; Kang J; Lei Y; Xue Y
    J Cell Biochem; 2019 Apr; 120(4):5386-5395. PubMed ID: 30367510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Upregulation of microRNA-1303 is a potential prognostic marker of non-small cell lung cancer.
    Chen J; Jiang T; Yu B; Li T; Zhao P; Yuan L; Qi J
    Cancer Biomark; 2020; 28(4):439-446. PubMed ID: 32508320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of ZNF746 suppresses invasion and epithelial to mesenchymal transition in H460 non-small cell lung cancer cells.
    Kim B; Sohn EJ; Jung JH; Shin EA; You OH; Im J; Kim SH
    Oncol Rep; 2014 Jan; 31(1):73-8. PubMed ID: 24145959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-16 inhibits the proliferation, migration and invasion of non-small cell lung carcinoma cells by down-regulating matrix metalloproteinase-19 expression.
    Tian G; Wang SW; Song M; Hu YF; Cao XN; Ge JW
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5260-5269. PubMed ID: 31298377
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discoidin domain receptor 1 is associated with poor prognosis of non-small cell lung cancer and promotes cell invasion via epithelial-to-mesenchymal transition.
    Miao L; Zhu S; Wang Y; Li Y; Ding J; Dai J; Cai H; Zhang D; Song Y
    Med Oncol; 2013; 30(3):626. PubMed ID: 23761027
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interaction of hnRNP K with MAP 1B-LC1 promotes TGF-β1-mediated epithelial to mesenchymal transition in lung cancer cells.
    Li L; Yan S; Zhang H; Zhang M; Huang G; Chen M
    BMC Cancer; 2019 Sep; 19(1):894. PubMed ID: 31492158
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Over-expression of LSD1 promotes proliferation, migration and invasion in non-small cell lung cancer.
    Lv T; Yuan D; Miao X; Lv Y; Zhan P; Shen X; Song Y
    PLoS One; 2012; 7(4):e35065. PubMed ID: 22493729
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Twist may be associated with invasion and metastasis of hypoxic NSCLC cells.
    Wei L; Sun JJ; Cui YC; Jiang SL; Wang XW; Lv LY; Xie L; Song XR
    Tumour Biol; 2016 Jul; 37(7):9979-87. PubMed ID: 26819207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long non-coding RNA SNHG6 promotes the growth and invasion of non-small cell lung cancer by downregulating miR-101-3p.
    Li K; Jiang Y; Xiang X; Gong Q; Zhou C; Zhang L; Ma Q; Zhuang L
    Thorac Cancer; 2020 May; 11(5):1180-1190. PubMed ID: 32147945
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Upregulation of TRIP13 promotes the malignant progression of lung cancer via the EMT pathway.
    Lu R; Zhou Q; Ju L; Chen L; Wang F; Shao J
    Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34184074
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating microRNA-590-5p functions as a liquid biopsy marker in non-small cell lung cancer.
    Khandelwal A; Seam RK; Gupta M; Rana MK; Prakash H; Vasquez KM; Jain A
    Cancer Sci; 2020 Mar; 111(3):826-839. PubMed ID: 31520555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SRPX2 promotes cell proliferation and invasion via activating FAK/SRC/ERK pathway in non-small cell lung cancer.
    Li X; Liu J; Sun H; Zou Y; Chen J; Chen Y; Chen C; Wu X
    Acta Biochim Pol; 2020 Jun; 67(2):165-172. PubMed ID: 32550700
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FOXD1 Promotes Cell Growth and Metastasis by Activation of Vimentin in NSCLC.
    Li D; Fan S; Yu F; Zhu X; Song Y; Ye M; Fan L; Lv Z
    Cell Physiol Biochem; 2018; 51(6):2716-2731. PubMed ID: 30562753
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling pathway.
    Wei CH; Wu G; Cai Q; Gao XC; Tong F; Zhou R; Zhang RG; Dong JH; Hu Y; Dong XR
    J Hematol Oncol; 2017 Jun; 10(1):125. PubMed ID: 28629431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MZT2A promotes NSCLC viability and invasion by increasing Akt phosphorylation via the MOZART2 domain.
    Wang H; Jiang X; Cheng Y; Ren H; Hu Y; Zhang Y; Su H; Zou Z; Wang Q; Liu Z; Zhang J; Qiu X
    Cancer Sci; 2021 Jun; 112(6):2210-2222. PubMed ID: 33754417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.